Skip to main content
Log in

1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Vitamin D3 derivatives and retinoids can induce cell cycle arrest, differentiation and cell death in many cell lines. These compounds can act cooperatively in some of their functions and may be of potential use either individually or in combination in the treatment of breast cancer. The effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), all-trans retinoic acid (ATRA) and several analogues were evaluated on malignant phenotypic traits of breast cancer cell lines MCF-7, T-47D and MDA-MB-231. Both 1,25(OH)2D3 and ATRA caused a decrease in anchorage independent colony formation in MCF-7 and T-47D cells in a dose-dependent manner. The effects of 1,25(OH)2D3 10−10 and 10−9M were synergistic with ATRA 10−8M in T-47D cells but were antagonistic in both MCF-7 and in T-47D cells at most concentrations. Both 1,25(OH)2D3 and ATRA individually induced an accumulation of MCF-7 cells in the G1 phase of the cell cycle and an associated increase in p21WAF1/Cip1, p27Kipl and a dephosphorylation of Rb but the effects were not additive. Both compounds inhibited the invasive capacity of MDA-MB-231 cells. 1,25(OH)2D3 but not ATRA caused an increase in E-cadherin levels in MDA-MB-231 cells. These two functions were not additive. The compounds 1,25(OH)2D3, a noncalcemic analogue 1,25(OH)2-16-ene-23-yne-D3, ATRA, AGN195183, an RARα-specific agonist, and AGN190168 (tazarotene), an RARβγ-selective agonist, induced differentiation as determined by measurements of lipid droplet formation. The individual effects of 1,25(OH)2-16-ene-23-yne-D3 combined with ATRA or with tazarotene at 10−9M each were additive in MCF-7 and MDA-MB-231 cells on lipid formation. The data demonstrate that both 1,25(OH)2D3, ATRA, and selected analogues induce a more differentiated phenotype in breast cancer cells with additive effects that are function- and cell-specific.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K, Knabbe C: Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73: 1341-1346, 1996

    Google Scholar 

  2. Carter CA, Pogribny M, Davidson A, Jackson CD, McGarrity LG, Morris, SM: Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (REL95-2) cells. Anticancer Res 16: 17-24, 1996

    Google Scholar 

  3. Barroga EF, Kadosawa T, Okumura M, Fujinaga T: Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines. Res Vet Sci 66: 231-36, 1999

    Google Scholar 

  4. Zhao XY, Ly LH, Peehi DM, Feldman D: Induction of androgen receptor by alpha, 25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140: 1205-1212, 1999

    Google Scholar 

  5. Mathiasen IS, Colston KW, Binderup L: EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 46: 365-37I, 1993

    Google Scholar 

  6. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB: A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761-3767, 1999

    Google Scholar 

  7. Green S, Chambon P: Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4: 309-314, 1988

    Google Scholar 

  8. Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441-446, 1992

    Google Scholar 

  9. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446-449, 1992

    Google Scholar 

  10. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG: RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991

    Google Scholar 

  11. Schrader M, Bendik I, Becker-Andre M, Carlberg C: Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 268: 17830-17836, 1993

    Google Scholar 

  12. Blutt SE, Allegretto EA, Pike JW, Weigel NL: 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergisticafly to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138: 1491-1497, 1997

    Google Scholar 

  13. Campbell, Park, Uskokovic MR, Dawson MJ, Koeffler HP: Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid. Br J Cancer 79: 101-107, 1999

    Google Scholar 

  14. Defacque H, Sevilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T: Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Leukemia 11: 221-227, 1997

    Google Scholar 

  15. James SY, Williams MA, Newland AC, Colston RW: Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 32: 143-154, 1999

    Google Scholar 

  16. James SY, Williams MA, Kelsey SM, Newland AC, Colston KW: The role of vitamin D derivatives and retinoids in the differentiation of human leukemia cells. Biochem Pharm 54: 625-634, 1997

    Google Scholar 

  17. Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M, Koeffler HP: Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res 19: 519-524, 1999

    Google Scholar 

  18. Kang S, Li XY, Duell EA, Voorhees JJ: The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1, 25-dihydroxyvitamin D3 in human skin in vivo. J Investigative Dermatology 108: 513-518, 1997

    Google Scholar 

  19. Gibson DF, Bikle DD, Harris J: All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J Cell Phys 174: 1-8, 1998

    Google Scholar 

  20. Sorensen S, Solvsten H, Politi Y, Kragballe K: Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Skin Pharm 10: 144-152, 1997

    Google Scholar 

  21. Tsonis PA, Sargent MD, Del Rio-Tsonis K, Jung JC: 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chondrogenesis of chick limb bud mesenchymal cells: interactions of their receptors. Int J Developmental Biol 40: 1053-1059, 1996

    Google Scholar 

  22. Fogh K, Solvsten H, Johnke H, Kragballe K: All-trans retinoic acid inhibits binding of 1,25 dihydroxy-vitam in D3 to the vitamin D receptor in cultured human keratinocytes. Exp Dermatol 5: 24-27, 1996

    Google Scholar 

  23. Carlberg C, Saurat JH: Vitamin D-retinoid association: molecular basis and clinical applications. J Investigative Derm, Symposium proceedings, 1: 82-86, 1996

    Google Scholar 

  24. Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R: 1,25-Dihydroxyvitam in D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60: 2040-2048, 2000.

    Google Scholar 

  25. Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N, Jakubowski AA, Gabrilove JL: Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells. Growth Factors 15: 41-60, 1997

    Google Scholar 

  26. Ramirez-Zacarias JL, Castro-Munozledo, F, Kuri-Harcuch W: Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97: 493-497, 1992

    Google Scholar 

  27. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G: Androgens markedly stimulate the accumulation of neutral lipids in the prostatic adenocarcinoma cell line LNCaP. Endocrinology 137: 4468-4474, 1996

    Google Scholar 

  28. Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ: Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem 272: 5007-5015, 1997

    Google Scholar 

  29. Wieder, R. Selection of Methods for Measuring Proliferation. In: Studzinski G, (ed) Cell Growth, Differentiation and Senescence: A Practical Approach. Oxford University Press, New York, NY, 1999, pp 1-32

    Google Scholar 

  30. Wang H, Rubin M, Fenig E, DeBlasio T, Mendelsohn J, Yahalom J, Wieder R: Basic FGF causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res 57: 1750-1757, 1997

    Google Scholar 

  31. Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J: Basic fibroblast growth factor confers growth inhibition andMitogen-activated Protein Kinase activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997

    Google Scholar 

  32. Greco WR, Bravo G, Parsons JC: The search for synergy: a critical review from a response, surface perspective. Pharmacol Rev 47: 331-385, 1995

    Google Scholar 

  33. Jacob K, Wach F, Holzapfel U, Uein R, Lengyel E, Buettner R, Bosserhoff AK: In vitro modultion of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 8: 211-219, 1998

    Google Scholar 

  34. Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP: 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prevent 6: 727-732, 1997

    Google Scholar 

  35. Korah R, Sysounthone V, Golowa Y, Wieder R: Basic fibroblast growth factor confers a more differentiated phenotype in MDA-MB-231 human breast cancer cells. Cancer Res. 60: 733-740, 2000

    Google Scholar 

  36. Seewaldt VL, Kim JH, Parker MB, Dietze FC, Srinivasan KV, CaIdwell LF: Dysregulated expression of cycl in D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated GO/G1-phase arrest and differentiation in vitro. Exp Cell Res 249: 70-85, 1999

    Google Scholar 

  37. Bhattacharjee M, Wientroub S, Vondcrhaar BK: Milk protein synthesis by mammary glands of vitamin D-deficient mice. Endocrinology 121: 865-874, 1987

    Google Scholar 

  38. Kiguchi K, Giometti C, Chubb CH, Fujiki H, Huberman E: Differentiation induction in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases I and 2A. Biochem Biophys Res Comm 189: 1261-1267, 1992

    Google Scholar 

  39. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E: Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2 /neu antigen. Mol Carcinogen 3: 350-362, 1990

    Google Scholar 

  40. Danielsson C, Torma H, Vahlquist A, Carlberg C: Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer 81: 467-470, 1999

    Google Scholar 

  41. Elstner B, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP: 20-epi-Vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55: 2822-2830, 1995

    Google Scholar 

  42. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995

    Google Scholar 

  43. Jing Y, Zhang J, Waxman S, Mira-y-Lopez R: Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent. Differentiation 60: 109-117, 1996

    Google Scholar 

  44. Liu M, lavarone A, Freedman LP: Transcriptional activation of the human p21WAF1/Cip1 gene by retinoic acid receptor; correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271: 31723-31728, 1996

    Google Scholar 

  45. Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the cdk inhibitor p21 by vitam in D3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Develop 10: 142-153, 1996

    Google Scholar 

  46. Lemon BD, Freedman LP: Selective effects of ligands on vitam in D3 receptor-and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol: 16: 1006-1016, 1996

    Google Scholar 

  47. Toma S, Isnardi L, Riccardi L, Bollag W: Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids. Anticancer Res 18: 935-942, 1998

    Google Scholar 

  48. Xu XC, Sneige N, Liu X, Nadagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R: Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res 57: 4992-4996, 1997

    Google Scholar 

  49. Paterson FC, Rudland PS: Identification of novel, stagespecific polypeptides associated with the differentiation of mammary epithelial stem cells to alveolar-like cells in culture. J Cell Phys 124: 525-538, 1985

    Google Scholar 

  50. Lee PP, Lee MT, Darcy KM, Shudo K, Ip MM: Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative RE80 with retinoic acid. Endocrinology 136: 1707-1717, 1995

    Google Scholar 

  51. Jimi S, Shono T, Tanaka M, Kono A, Yamada Y, Shudo K, Kuwano M: Effect of retinoic acid on morphological changes of human pancreatic cancer cells on collagen gels: a possible association with the metastatic potentials. Oncol Res 10: 7-14, 1998

    Google Scholar 

  52. Campbell MJ, Elstner E, Holden S, Uskokovic M, Koeffler HP: Inhibition of proliferation of prostate cancer cells by a 1 9-nor-hexafluoride vitamin D3 analogue involves the induction of p21WAF1, p27Kip1 and E-cadherin. J Mol Endocrin 19: 15-27, 1997

    Google Scholar 

  53. Benbow U, Schoenermark MP, Orndorff KA, Givan AL, Brinckerhoff CE: Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metast 17: 231-238, 1999

    Google Scholar 

  54. Benbow U, Schoenermark MP, Mitchell TI, Rutter JL, Shimokawa K, Nagase H, Brinckerhoff CE: A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 274: 25371-25378, 1999

    Google Scholar 

  55. Schoenermark MP, Mitchell TI, Rutter JL, Reczek PR, Brinckerhoff CE: Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis. Ann New York Acad Sci 878: 466-486, 1999

    Google Scholar 

  56. Webber MM, Waghray A: Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res 1: 755-761, 1995

    Google Scholar 

  57. Vermeulen S, Van Marck V, Van Hoorde L, Van Roy F, Bracke M, Marcel M: Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract 192: 694-707, 1996

    Google Scholar 

  58. Benbow U, Rutter JL, Lowrey CU, Briuckerhoff CE: Transcriptional repression of the human collagenase-1 (MMP-1 gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. Br J Cancer 79: 221-228, 1999

    Google Scholar 

  59. Waghray A, Webber MM: Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells. Clin Cancer Res 1: 747-753, 1995

    Google Scholar 

  60. Vo UP, Lee MK, Crowe DL: Alpha2betal integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. Int J Onc 13: 1127-1134, 1998

    Google Scholar 

  61. Pereda MP, Hopfner U, Pagotto U, Renner U, UhI E, Arzt E, Missale C, Stalla GK: Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion. Br J Cancer 81: 381-386, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Q., Lee, D., Sysounthone, V. et al. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67, 157–168 (2001). https://doi.org/10.1023/A:1010643323268

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010643323268

Navigation